92 related articles for article (PubMed ID: 9657047)
1. Hepatic extraction of tacrolimus in rats with experimental liver diseases.
Sasa H; Hashimoto Y; Shimizu T; Inui K
Biol Pharm Bull; 1998 Jun; 21(6):610-4. PubMed ID: 9657047
[TBL] [Abstract][Full Text] [Related]
2. Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats.
Hashimoto Y; Sasa H; Shimomura M; Inui K
Pharm Res; 1998 Oct; 15(10):1609-13. PubMed ID: 9794505
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
[TBL] [Abstract][Full Text] [Related]
4. Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.
Musuamba FT; Mourad M; Haufroid V; Delattre IK; Verbeeck RK; Wallemacq P
Ther Drug Monit; 2009 Dec; 31(6):734-42. PubMed ID: 19855314
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and bioavailability of tacrolimus in rats with experimental renal dysfunction.
Okabe H; Hashimoto Y; Inui KI
J Pharm Pharmacol; 2000 Dec; 52(12):1467-72. PubMed ID: 11197074
[TBL] [Abstract][Full Text] [Related]
6. Disposition of L-732,531, a potent immunosuppressant, in rats and baboons.
Karanam BV; Miller RR; Colletti A; Montgomery T; Carey KD; Hawkins T; Tang YS; Lavin M; Stearns RA; Chiu SH; Vincent SH
Drug Metab Dispos; 1998 Oct; 26(10):949-57. PubMed ID: 9763399
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of tacrolimus and mycophenolic acid are altered, but recover at different times during hepatic regeneration in rats.
Tian H; Ou J; Strom SC; Venkataramanan R
Drug Metab Dispos; 2005 Mar; 33(3):329-35. PubMed ID: 15523045
[TBL] [Abstract][Full Text] [Related]
8. No effect of water deprivation for 48 hours on the pharmacokiinetics of intravenous tacrolimus in rats.
Son IJ; Moon YJ; Lee MG; Sohn YT
Res Commun Mol Pathol Pharmacol; 2000; 107(3-4):279-89. PubMed ID: 11484882
[TBL] [Abstract][Full Text] [Related]
9. Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus.
Shimomura M; Masuda S; Saito H; Sakamoto S; Uemoto S; Tanaka K; Inui K
J Surg Res; 2002 Apr; 103(2):215-22. PubMed ID: 11922737
[TBL] [Abstract][Full Text] [Related]
10. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion.
Chow FS; Piekoszewski W; Jusko WJ
Drug Metab Dispos; 1997 May; 25(5):610-6. PubMed ID: 9152601
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassay of plasma ligandin: a sensitive index of experimental hepatocellular necrosis.
Bass NM; Kirsch RE; Tuff SA; Saunders SJ
Gastroenterology; 1978 Oct; 75(4):589-94. PubMed ID: 710828
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
Staatz CE; Willis C; Taylor PJ; Tett SE
Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of increased bioavailability of tacrolimus in rats with experimental renal dysfunction.
Okabe H; Yano I; Hashimoto Y; Saito H; Inui K
J Pharm Pharmacol; 2002 Jan; 54(1):65-70. PubMed ID: 11829131
[TBL] [Abstract][Full Text] [Related]
14. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection.
Capron A; Lerut J; Verbaandert C; Mathys J; Ciccarelli O; Vanbinst R; Roggen F; De Reyck C; Lemaire J; Wallemacq PE
Ther Drug Monit; 2007 Jun; 29(3):340-8. PubMed ID: 17529892
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
Saint-Marcoux F; Debord J; Parant F; Labalette M; Kamar N; Rostaing L; Rousseau A; Marquet P
Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655
[TBL] [Abstract][Full Text] [Related]
16. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
Westley IS; Taylor PJ; Salm P; Morris RG
Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
[TBL] [Abstract][Full Text] [Related]
17. Apparent lack of effect of P-glycoprotein on the gastrointestinal absorption of a substrate, tacrolimus, in normal mice.
Chiou WL; Chung SM; Wu TC
Pharm Res; 2000 Feb; 17(2):205-8. PubMed ID: 10751036
[TBL] [Abstract][Full Text] [Related]
18. The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects.
Möller A; Iwasaki K; Kawamura A; Teramura Y; Shiraga T; Hata T; Schäfer A; Undre NA
Drug Metab Dispos; 1999 Jun; 27(6):633-6. PubMed ID: 10348790
[TBL] [Abstract][Full Text] [Related]
19. Increased bioavailability of tacrolimus after rectal administration in rats.
Sakai M; Hobara N; Hokama N; Kameya H; Ohshiro S; Sakanashi M; Saitoh H
Biol Pharm Bull; 2004 Sep; 27(9):1480-2. PubMed ID: 15340245
[TBL] [Abstract][Full Text] [Related]
20. Application of a Volumetric Absorptive Microsampling Device to a Pharmacokinetic Study of Tacrolimus in Rats: Comparison with Wet Blood and Plasma.
Kita K; Noritake K; Mano Y
Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):91-102. PubMed ID: 29943105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
